Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.41B |
| 2 |
Apple
AAPL
|
+$949M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$788M |
| 4 |
Microsoft
MSFT
|
+$654M |
| 5 |
Broadcom
AVGO
|
+$568M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.26B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$702M |
| 3 |
Tesla
TSLA
|
+$694M |
| 4 |
Micron Technology
MU
|
+$601M |
| 5 |
Strategy Inc
MSTR
|
+$512M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.97% |
| 2 | Financials | 0.89% |
| 3 | Consumer Discretionary | 0.83% |
| 4 | Healthcare | 0.75% |
| 5 | Communication Services | 0.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NINE
11926
CALL
DELISTED
Nine Energy Service
NINE
| $18.6K | ﹤0.01% |
+16,600
| New | +$19.6K |
|
|
BLRX
11927
BioLineRX
BLRX
$11.8M
| $18.5K | ﹤0.01% |
2,180
+1,729
| +383% | +$25.5K |
|
|
NOTE
11928
PUT
DELISTED
FiscalNote
NOTE
| $18.3K | ﹤0.01% |
+1,425
| New | +$17.4K |
|
|
UBX
11929
DELISTED
Unity Biotechnology
UBX
| $18.2K | ﹤0.01% |
+18,690
| New | +$23.2K |
|
11930
PUT
Heron Therapeutics
HRTX
$59.3M
| $18.2K | ﹤0.01% |
11,900
-39,600
| -77% | -$64.2K |
|
11931
CALL
Actinium Pharmaceuticals
ATNM
$31.7M
| $18.1K | ﹤0.01% |
+14,400
| New | +$22.3K |
|
|
NB
11932
NioCorp Developments
NB
$630M
| $17.9K | ﹤0.01% |
11,529
-32,607
| -74% | -$51.7K |
|
11933
TruGolf
TRUG
$1.27M
| $17.1K | ﹤0.01% |
+51
| New | +$15.8K |
|
11934
DarioHealth
DRIO
$68.9M
| $17.1K | ﹤0.01% |
+1,088
| New | +$18.8K |
|
|
CTHR
11935
DELISTED
Charles & Colvard Ltd
CTHR
| $16.7K | ﹤0.01% |
+12,558
| New | +$17.6K |
|
|
DUO
11936
Fangdd Network Group
DUO
$27M
| $16.6K | ﹤0.01% |
+1,733
| New | +$29.7K |
|
11937
Network-1 Technologies
NTIP
$35.9M
| $16.4K | ﹤0.01% |
12,301
-24,030
| -66% | -$31.9K |
|
11938
System1
SST
$16.1M
| $16.2K | ﹤0.01% |
1,808
-859
| -32% | -$8.64K |
|
|
ABLLW
11939
DELISTED
Abacus Life Warrant
ABLLW
| $16.2K | ﹤0.01% |
+14,991
| New | +$19.9K |
|
11940
PUT
Karyopharm Therapeutics
KPTI
$44.5M
| $16.1K | ﹤0.01% |
1,580
-467
| -23% | -$5.65K |
|
|
OPI
11941
CALL
DELISTED
Office Properties Income Trust
OPI
| $16.1K | ﹤0.01% |
16,100
-38,400
| -70% | -$59.2K |
|
|
FRGE
11942
CALL
DELISTED
Forge Global Holdings
FRGE
| $15.7K | ﹤0.01% |
1,127
-26
| -2% | -$428 |
|
|
ADAP
11943
DELISTED
Adaptimmune Therapeutics
ADAP
| $15.7K | ﹤0.01% |
29,150
-160,322
| -85% | -$117K |
|
|
NB
11944
PUT
NioCorp Developments
NB
$630M
| $15.5K | ﹤0.01% |
10,000
-3,000
| -23% | -$4.75K |
|
11945
Vista Gold
VGZ
$337M
| $15.1K | ﹤0.01% |
+27,063
| New | +$17.1K |
|
11946
Indaptus Therapeutics
INDP
$152M
| $15K | ﹤0.01% |
+637
| New | +$20.2K |
|
11947
PUT
MoneyHero
MNY
$37.9M
| $15K | ﹤0.01% |
13,400
-50,100
| -79% | -$56.7K |
|
|
BFLY.WS
11948
DELISTED
Butterfly Network Inc Warrants
BFLY.WS
| $14.7K | ﹤0.01% |
+115,835
| New | +$14K |
|
|
WDH
11949
Waterdrop
WDH
$357M
| $14.6K | ﹤0.01% |
+12,352
| New | +$14.4K |
|
11950
CALL
Newegg Commerce
NEGG
$378M
| $14.5K | ﹤0.01% |
1,810
-3,605
| -67% | -$43.4K |
|
Similar funds
Jeff Yass's Q4 2024 Portfolio in Review
As of Q4 2024, Jeff Yass held 13,659 positions worth $663B, up 16% from $572B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass deployed $61.2B of net new capital in Q4 2024, opening 1,862 new positions and adding to 5,386 existing holdings. Its largest new stake was State Street SPDR S&P 400 Mid Cap Value ETF: 1,000,000 shares worth $80.2M.
By sector, the portfolio is most concentrated in Technology at 2% of assets, up from 1.8% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $1.26B trimmed.
- Jeff Yass's largest Q4 2024 buy was State Street SPDR S&P 400 Mid Cap Value ETF: 1,000,000 shares worth $80.2M.
- Jeff Yass added most to Invesco QQQ Trust in Q4 2024, an estimated $1.41B increase.
- Jeff Yass's biggest Q4 2024 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $1.26B.
- Jeff Yass fully exited NextEra Energy 7.299% Corporate Units in Q4 2024, selling an estimated $112M.
- Jeff Yass's ten largest holdings make up 28% of its $663B portfolio in Q4 2024.
- Jeff Yass opened 1,862 new positions and closed 1,590 in Q4 2024.
- Jeff Yass's portfolio value rose 16% quarter-over-quarter to $663B.
Based on Susquehanna International Group's 13F filing for Q4 2024, filed 14 Feb 2025.